Levothyroxine (Synthroid)
Levothyroxine
Abbott Laboratories S.A. (Pty) Ltd
Registration
- Applicant
- Abbott Laboratories S.A. (Pty) Ltd
- Registrations
- 12
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Synthroid 25 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 25,0 mcg | 25 mcg | 42067042/21.3/0670 | Registered | S3 | None |
| Synthroid 50 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 50,0 mcg | 50 mcg | 42067142/21.3/0671 | Registered | S3 | None |
| Synthroid 75 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 75,0 mcg | 75 mcg | 42067242/21.3/0672 | Registered | S3 | None |
| Synthroid 88 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 88,0 mcg | 88 mcg | 42067342/21.3/0673 | Registered | S3 | None |
| Synthroid 100 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 100,0 mcg | 100 mcg | 42067442/21.3/0674 | Registered | S3 | None |
| Synthroid 112 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 112,0 mcg | 112 mcg | 42067542/21.3/0675 | Registered | S3 | None |
| Synthroid 125 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 125,0 mcg | 125 mcg | 42067642/21.3/0676 | Registered | S3 | None |
| Synthroid 137 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 137,0 mcg | 137 mcg | 42067742/21.3/0677 | Registered | S3 | None |
| Synthroid 150 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 150,0 mcg | 150 mcg | 42067842/21.3/0678 | Registered | S3 | None |
| Synthroid 175 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 175,0 mcg | 175 mcg | 42067942/21.3/0679 | Registered | S3 | None |
| Synthroid 200 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 200,0 mcg | 200 mcg | 42068042/21.3/0680 | Registered | S3 | None |
| Synthroid 300 MCG EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 300,0 mcg | 300 mcg | 42068142/21.3/0681 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Levothyroxine sodium
S3: Levothyroxine
Consolidated Schedules 06 July 2026, line 3888
Pharmacological class: Thyroid preparations. (class 21.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
Drag to rotate. Structure from PubChem CID 5819.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.